FR2532849B1 - Composition pharmaceutique solide contenant des antibiotiques b-lactamiques, son procede de preparation et procede pour stabiliser une composition pharmaceutique - Google Patents
Composition pharmaceutique solide contenant des antibiotiques b-lactamiques, son procede de preparation et procede pour stabiliser une composition pharmaceutiqueInfo
- Publication number
- FR2532849B1 FR2532849B1 FR8314396A FR8314396A FR2532849B1 FR 2532849 B1 FR2532849 B1 FR 2532849B1 FR 8314396 A FR8314396 A FR 8314396A FR 8314396 A FR8314396 A FR 8314396A FR 2532849 B1 FR2532849 B1 FR 2532849B1
- Authority
- FR
- France
- Prior art keywords
- pharmaceutical composition
- preparation
- stabilizing
- composition containing
- solid pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8225853 | 1982-09-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2532849A1 FR2532849A1 (fr) | 1984-03-16 |
| FR2532849B1 true FR2532849B1 (fr) | 1986-08-22 |
Family
ID=10532830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8314396A Expired FR2532849B1 (fr) | 1982-09-10 | 1983-09-09 | Composition pharmaceutique solide contenant des antibiotiques b-lactamiques, son procede de preparation et procede pour stabiliser une composition pharmaceutique |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US4582830A (fr) |
| JP (1) | JPS5973518A (fr) |
| KR (1) | KR880001094B1 (fr) |
| AT (1) | AT388671B (fr) |
| AU (1) | AU566245B2 (fr) |
| BE (1) | BE897721A (fr) |
| CA (1) | CA1215647A (fr) |
| CH (1) | CH655008A5 (fr) |
| DE (1) | DE3332616C2 (fr) |
| DK (1) | DK161304C (fr) |
| ES (1) | ES525492A0 (fr) |
| FR (1) | FR2532849B1 (fr) |
| GB (1) | GB2126479B (fr) |
| IE (1) | IE55720B1 (fr) |
| IT (1) | IT1197708B (fr) |
| NL (1) | NL189948C (fr) |
| NZ (1) | NZ205539A (fr) |
| PT (1) | PT77323B (fr) |
| SE (1) | SE464615B (fr) |
| ZA (1) | ZA836703B (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4626534A (en) * | 1984-07-23 | 1986-12-02 | Eli Lilly And Company | Pharmaceutical formulation |
| AT393452B (de) * | 1985-08-05 | 1991-10-25 | Bristol Myers Squibb Co | Verfahren zur herstellung eines cephalosporinpraeparates zur herstellung einer injektionsloesung |
| WO1988009173A1 (fr) * | 1987-05-27 | 1988-12-01 | Akzo N.V. | COMPOSITiONS ANTIBIOTIQUES SECHES ET RAPIDEMENT SOLUBLES DE beta-LACTAM |
| IE61679B1 (en) * | 1987-08-10 | 1994-11-16 | Fujisawa Pharmaceutical Co | Water-soluble antibiotic composition and water-soluble salts of new cephem compounds |
| US5922461A (en) * | 1994-12-08 | 1999-07-13 | Otsuka Pharmaceutical Factory, Inc. | Method for inhibiting adsorption of container-derived contaminants on drugs and contamination-inhibitory containers |
| HRP970281B1 (en) * | 1996-05-28 | 2002-04-30 | Merck & Co Inc | Carbapenem antibiotic, composition and method of preparation |
| CA2239331C (fr) * | 1998-05-29 | 1999-11-30 | Bernard Charles Sherman | Comprimes pharmaceutiques a base de cefuroxime axetil |
| ES2686898T3 (es) | 2003-04-28 | 2018-10-22 | Takeda Pharmaceutical Company Limited | Composición para inyección |
| JP4700291B2 (ja) * | 2003-04-28 | 2011-06-15 | 武田薬品工業株式会社 | 注射用組成物 |
| EP1625859A1 (fr) * | 2004-08-13 | 2006-02-15 | Access Group ApS | Procédé de préparation d'un emballage contenant substances stérilisées, et emballage contenant pénicilline stérilisée |
| CN102920710B (zh) * | 2012-11-16 | 2014-05-28 | 罗诚 | 一种头孢地嗪化合物的药物组合物 |
| CN103432137B (zh) * | 2013-08-28 | 2015-01-28 | 芦红代 | 头孢西丁的药物组合物 |
| CN113350511B (zh) * | 2021-03-01 | 2024-01-02 | 郎俊娜 | 一种新型注射用无菌粉末灌装混合保护气 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB760087A (en) * | 1952-10-16 | 1956-10-31 | Novo Terapeutisk Labor As | Process of increasing the physical stability of aqueous suspensions of penicillin compounds |
| GB737242A (en) * | 1952-10-16 | 1955-09-21 | Novo Terapeutisk Labor As | Process of increasing the physical stability of aqueous suspensions of penicillin compounds |
| GB1132583A (en) * | 1964-12-16 | 1968-11-06 | Glaxo Lab Ltd | Pharmaceutical compositions containing cephalosporins |
| GB1276839A (en) * | 1968-08-02 | 1972-06-07 | Sandoz Products Ltd | Antibiotic compositions |
| AT307616B (de) * | 1969-05-02 | 1973-05-25 | Biochemie Gmbh | Verfahren zur Herstellung einer Brausezubereitung |
| GB1380741A (en) * | 1971-02-05 | 1975-01-15 | Squibb & Sons Inc | Antibiotic compositions and their preparation |
| US3940483A (en) * | 1971-02-05 | 1976-02-24 | E. R. Squibb & Sons, Inc. | Antibiotic compositions and method |
| LU65921A1 (fr) * | 1972-08-18 | 1974-02-21 | ||
| US4160829A (en) * | 1972-12-22 | 1979-07-10 | Gist-Brocades N.V. | Antibacterial 1,2,4-oxadiazolylacetamido cephalosporins |
| US3969524A (en) * | 1974-08-13 | 1976-07-13 | Hoffmann-La Roche Inc. | Stable amoxicillin dosage form |
| GB1463563A (en) * | 1974-10-10 | 1977-02-02 | Beecham Group Ltd | Pharmaceutical compositions |
| DE2461969A1 (de) * | 1974-12-31 | 1976-07-08 | Behringwerke Ag | Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen |
| CA1051780A (fr) * | 1975-04-09 | 1979-04-03 | Bahram Farhadieh | Compose stable de chelocardin |
| GB1575905A (en) * | 1976-04-28 | 1980-10-01 | Glaxo Lab Ltd | Salt of cefuroxime |
| GB1504767A (en) * | 1976-08-23 | 1978-03-22 | Beecham Group Ltd | Antibiotic compositions |
| JPS5329936A (en) * | 1976-08-31 | 1978-03-20 | Takeda Chem Ind Ltd | Antibiotic composition |
| FR2403078A1 (fr) * | 1977-09-19 | 1979-04-13 | Lafon Labor | Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic |
| IT1109207B (it) * | 1977-10-10 | 1985-12-16 | Glaxo Group Ltd | Composti b-lattamici composizioni antibiotiche che li contengono e procedimento per prepararli |
| AR229883A1 (es) * | 1978-05-26 | 1983-12-30 | Glaxo Group Ltd | Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato |
| PT70225A (en) * | 1978-10-03 | 1979-10-01 | Gist Brocades Nv | Process for the preparation of sodium amoxicillin preparations |
| US4235900A (en) * | 1978-11-15 | 1980-11-25 | E. R. Squibb & Sons, Inc. | Cephradine compositions |
| FR2445833A1 (fr) * | 1979-01-04 | 1980-08-01 | Chimie Biolog | Nouveaux sels d'antibiotiques amines a cycle beta lactame |
| US4329453A (en) * | 1979-10-02 | 1982-05-11 | Glaxo Group Limited | Cephalosporin antibiotic |
-
1983
- 1983-09-08 ES ES525492A patent/ES525492A0/es active Granted
- 1983-09-09 DE DE3332616A patent/DE3332616C2/de not_active Expired - Lifetime
- 1983-09-09 IT IT48950/83A patent/IT1197708B/it active Protection Beyond IP Right Term
- 1983-09-09 AT AT0322783A patent/AT388671B/de not_active IP Right Cessation
- 1983-09-09 US US06/530,655 patent/US4582830A/en not_active Expired - Lifetime
- 1983-09-09 SE SE8304857A patent/SE464615B/sv not_active IP Right Cessation
- 1983-09-09 DK DK409183A patent/DK161304C/da not_active IP Right Cessation
- 1983-09-09 ZA ZA836703A patent/ZA836703B/xx unknown
- 1983-09-09 GB GB08324133A patent/GB2126479B/en not_active Expired
- 1983-09-09 AU AU18975/83A patent/AU566245B2/en not_active Expired
- 1983-09-09 FR FR8314396A patent/FR2532849B1/fr not_active Expired
- 1983-09-09 NL NLAANVRAGE8303125,A patent/NL189948C/xx not_active IP Right Cessation
- 1983-09-09 BE BE0/211503A patent/BE897721A/fr not_active IP Right Cessation
- 1983-09-09 NZ NZ205539A patent/NZ205539A/en unknown
- 1983-09-09 KR KR1019830004246A patent/KR880001094B1/ko not_active IP Right Cessation
- 1983-09-09 CH CH4937/83A patent/CH655008A5/de not_active IP Right Cessation
- 1983-09-09 PT PT77323A patent/PT77323B/pt active IP Right Revival
- 1983-09-09 JP JP58165286A patent/JPS5973518A/ja active Granted
- 1983-09-09 IE IE2118/83A patent/IE55720B1/en not_active IP Right Cessation
- 1983-09-09 CA CA000436412A patent/CA1215647A/fr not_active Expired
-
1987
- 1987-06-04 US US07/058,119 patent/US4803196A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2531087B1 (fr) | Nouvelle forme d'ester de cefuroxime, procede pour sa preparation et composition pharmaceutique la contenant | |
| BE890574A (fr) | Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant | |
| FR2505835B1 (fr) | Nouvelles 1,2-diaminocyclobutene-3,4-diones, leur procede de preparation et composition pharmaceutique les contenant | |
| FR2569402B1 (fr) | Derives d'acide 3,5-pyridine-dicarboxylique, procede pour leur preparation et composition pharmaceutique les contenant | |
| OA07282A (fr) | Composition pharmaceutique lyophilisée contenant de l'interféron procédé pour la préparation et procédé pour sa stabilisation. | |
| FR2518095B1 (fr) | Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant | |
| PT64770A (fr) | Procede pour la preparation d'une composition insecticide contenant ethers benzoilureide-difenilicos | |
| FR2532849B1 (fr) | Composition pharmaceutique solide contenant des antibiotiques b-lactamiques, son procede de preparation et procede pour stabiliser une composition pharmaceutique | |
| FR2495154B1 (fr) | 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant | |
| PT64771A (fr) | Procede pour la preparation d'une composition insecticide contenant ethers benzoilureide-nitro-difenilicos | |
| FR2411839B1 (fr) | Derives de l'acide cephalosporanique, procedes pour leur preparation et composition pharmaceutique les contenant | |
| DE3380627D1 (en) | Cephem compounds, process and intermediates for their preparation and pharmaceutical compositions containing them | |
| BE892552A (fr) | Nouveaux amido-aminoacides, compositions pharmaceutiques les contenant et procede de preparation de ces amido-aminoacides | |
| FR2480603B1 (fr) | Composition pharmaceutique pour administration par voie orale contenant de la cytidine-diphosphocholine | |
| FR2483415B1 (fr) | Nouvelles quinoxaline-2-yl-ethenylcetones, leur procede de preparation et aliments pour animaux les contenant | |
| OA07585A (fr) | Nouveaux composés hétérocycliques, leur procédé de préparation et composition pharmaceutique les contenant. | |
| FR2518091B1 (fr) | 23-dehydro-25-hydroxyvitamine d3, son procede de preparation et composition pharmaceutique la renfermant | |
| FR2519021B1 (fr) | Procede de stabilisation de la serrapeptase, composition contenant cette serrapeptase stabilisee et preparation de cette composition | |
| FR2528422B1 (fr) | Nouveaux derives du 1,2,3,4-tetrahydronaphtalene, procede pour leur preparation et composition pharmaceutique contenant ces derives | |
| RO91021A (fr) | Procede de soutenement pour la stabilisation d'une masse rocheuse | |
| PT77751A (fr) | Procede de preparation de derives benzylideniques soufres et de compositions pharmaceutiques le contenant | |
| PT77428B (fr) | Procede pour preparer de nouvelles amino-2-substitue-5-oxazoli-nes-2 et des compositions les contenant | |
| BE896628A (fr) | Derives de cycloalcanes, procede pour leur preparation et compositions les contenant. | |
| FR2513994B1 (fr) | Tripeptides anorexigenes, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| FR2547821B1 (fr) | Sel de 2-piperazinopyrimidine, procede pour sa preparation et compositions pharmaceutiques en contenant |